(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(-0.97%) $83.04
(-1.16%) $1.619
(-0.31%) $2 340.00
(-0.33%) $27.45
(0.49%) $926.60
(-0.14%) $0.933
(-0.12%) $11.01
(-0.22%) $0.799
(0.00%) $92.17
Live Chart Being Loaded With Signals
Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, and European Union...
Stats | |
---|---|
本日の出来高 | 423 867 |
平均出来高 | 149 345 |
時価総額 | 12.25M |
EPS | £0 ( 2024-04-02 ) |
Last Dividend | £0 ( N/A ) |
Next Dividend | £0 ( N/A ) |
P/E | -4.15 |
ATR14 | £0 (0.00%) |
Proteome Sciences PLC 相関
10 最も正の相関 |
---|
10 最も負の相関 |
---|
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
Proteome Sciences PLC 財務諸表
Annual | 2023 |
収益: | £23.50B |
総利益: | £23.49B (99.99 %) |
EPS: | £0.270 |
FY | 2023 |
収益: | £23.50B |
総利益: | £23.49B (99.99 %) |
EPS: | £0.270 |
FY | 2022 |
収益: | £23.74B |
総利益: | £23.73B (99.99 %) |
EPS: | £17.02 |
FY | 2021 |
収益: | £5.13M |
総利益: | £2.96M (57.71 %) |
EPS: | £0.000240 |
Financial Reports:
No articles found.
Proteome Sciences PLC
Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, and European Union. The company offers SysQuant provides comprehensive analysis of protein activity across regulatory and signaling pathways; TMT MS2 for analyzing cells and tissues when no phosphopeptide enrichment is required; and TMT MS3, a method for biomarker discovery in plasma and other complex samples where quantitative accuracy is the important factor. It also provides TMT Calibrator that analyzes diseased or treated tissue in parallel with peripheral fluids; TMT SRM, a targeted assay format that enables the rapid validation of biomarker candidates; and SRM assay, a targeted mass spectrometry assay format for the routine measurement of biomarkers. In addition, the company offers bioinformatics tools, including Proteome Discoverer for peptide sequence and TMT quantitation; SQuaT,CalDIT, and DIANA for normalized quantitative values and functional annotation at peptide and protein level; FeaST for visualization of data quality, class identifier model, and biomarker candidate lists; and FAT for identification of biological processes and cellular components showing variance. It primarily serves pharmaceutical and biotechnology companies, and academic research institutes. The company was incorporated in 1993 and is based in Cobham, the United Kingdom.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。